Guzmán Alonso, MD is a medical oncologist consultant dedicated to clinical research at NEXT Barcelona. He obtained his Medical Degree by the University of Cantabria in 2009 and completed his specialized formation in Medical Oncology at Hospital Clínico Universitario de Valencia, Madrid during 2014 and 2019. Once completing his residency, and with the aspiration of furthering her career as an Investigator, Dr. Alonso moved to Barcelona as a fully registered oncologist and completed a 2-year Clinical Research Fellowship focused on Early Drug Devoplment at VHIO (Vall d’Hebron Institute of Oncology). Afterwards, he has continued working at VHIO as a consultant.
In 2022, he joined NEXT Barcelona as a clinical researcher dedicated to early clinical trials and drug development with special focus on targeted therapies, DNA repair and cancer immunotherapy. He is currently the Principal Investigator/Co-Investigator of over 40 early phase clinical trials of novel anticancer agents for patients with advanced solid tumors and he has pioneered the development of new anticancer drugs.